The Cooper Companies, Inc. (NASDAQ:COO) Stock Position Lowered by Illinois Municipal Retirement Fund

Illinois Municipal Retirement Fund lessened its position in The Cooper Companies, Inc. (NASDAQ:COO) by 42.4% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 6,366 shares of the medical device company’s stock after selling 4,686 shares during the quarter. Illinois Municipal Retirement Fund’s holdings in Cooper Companies were worth $585,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the company. Victory Capital Management Inc. increased its stake in Cooper Companies by 23.0% in the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock valued at $435,856,000 after buying an additional 737,726 shares during the period. JPMorgan Chase & Co. increased its stake in Cooper Companies by 13.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock valued at $543,979,000 after buying an additional 573,908 shares during the period. Swedbank AB increased its stake in Cooper Companies by 14.0% in the 4th quarter. Swedbank AB now owns 1,629,602 shares of the medical device company’s stock valued at $149,809,000 after buying an additional 200,000 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Cooper Companies by 11.9% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company’s stock valued at $200,665,000 after buying an additional 194,118 shares during the period. Finally, Soros Fund Management LLC acquired a new position in Cooper Companies in the 3rd quarter valued at approximately $19,310,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on COO. Wells Fargo & Company upped their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Citigroup reduced their price objective on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Finally, Morgan Stanley reduced their price objective on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, Cooper Companies currently has a consensus rating of “Moderate Buy” and a consensus target price of $117.22.

Cooper Companies Price Performance

NASDAQ COO opened at $91.65 on Tuesday. The stock has a 50-day simple moving average of $92.63 and a 200 day simple moving average of $99.59. The Cooper Companies, Inc. has a twelve month low of $84.76 and a twelve month high of $112.38. The stock has a market capitalization of $18.29 billion, a PE ratio of 47.00, a P/E/G ratio of 2.25 and a beta of 1.00. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. The company had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company’s quarterly revenue was up 9.8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.87 earnings per share. Research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.